Cognitive impairment among prostate cancer patients: An overview of reviews

Treanor, Charlene; Li, J.; Donnelly, Michael

doi:10.1111/ecc.12642

Cited by 44 publications

(44 citation statements)

References 56 publications

(180 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The development of cognitive impairment in cancer patients is linked to various psychosocial or tumor-related factors [ 10 ]. However, there are no systematic assessment tools to predict the risk for CRCI complications in colon cancer patients after chemotherapy [ 11 ].…”

Section: Introductionmentioning

confidence: 99%

[Retracted] A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment

Zhou

Fei

Han

et al. 2021

BioMed Research International

View full text Add to dashboard Cite

Background. A prediction model can be developed to predict the risk of cancer-related cognitive impairment in colorectal cancer patients after chemotherapy. Methods. A regression analysis was performed on 386 colorectal cancer patients who had undergone chemotherapy. Three prediction models (random forest, logistic regression, and support vector machine models) were constructed using collected clinical and pathological data of the patients. Calibration and ROC curves and C -indexes were used to evaluate the selected models. A decision curve analysis (DCA) was used to determine the clinical utility of the line graph. Results. Three prediction models including a random forest, a logistic regression, and a support vector machine were constructed. The logistic regression model had the strongest predictive power with an area under the curve (AUC) of 0.799. Age, BMI, colostomy, complications, CRA, depression, diabetes, QLQ-C30 score, exercise, hypercholesterolemia, diet, marital status, education level, and pathological stage were included in the nomogram. The C -index (0.826) and calibration curve showed that the nomogram had good predictive ability and the DCA curves indicated that the model had strong clinical utility. Conclusions. A prediction model with good predictive ability and practical clinical value can be developed for predicting the risk of cognitive impairment in colorectal cancer after chemotherapy.

show abstract

Section: Introductionmentioning

confidence: 99%

[Retracted] A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment

Zhou

Fei

Han

et al. 2021

BioMed Research International

View full text Add to dashboard Cite

show abstract

“…Cardiopulmonary fitness has traditionally been assessed before radical prostatectomy, as part of enhanced recovery pathways [5] or prior to prehabilitation [6]. It is well recognised that surgery can have a significant impact on catabolism and oxygen demand, and the length and extent of surgery is directly related to the risk of developing post-surgery complications [7].…”

Section: Introductionmentioning

confidence: 99%

The Siconolfi step test: a valid and reliable assessment of cardiopulmonary fitness in older men with prostate cancer

Lemańska

Poole

Aning

et al. 2019

Eur Rev Aging Phys Act

View full text Add to dashboard Cite

BackgroundAssessing fitness and promoting regular physical activity can improve health outcomes and early recovery in prostate cancer. This is however, underutilised in clinical practice. The cardiopulmonary exercise test (CPET) is increasingly being used pre-treatment to measure aerobic capacity and peak oxygen consumption (VO2peak - a gold standard in cardiopulmonary fitness assessment). However, CPET requires expensive equipment and may not always be appropriate. The Siconolfi step test (SST) is simpler and cheaper, and could provide an alternative.The aim of this study was to evaluate the validity and reliability of SST for predicting cardiopulmonary fitness in men with prostate cancer. Men were recruited to this two-centre study (Surrey and Newcastle, United Kingdom) after treatment for locally advanced prostate cancer. They had one or more of three risk factors: elevated blood pressure, overweight (BMI > 25), or androgen deprivation therapy (ADT). Cardiopulmonary fitness was measured using SST and cycle ergometry CPET, at two visits three months apart. The validity of SST was assessed by comparing it to CPET. The VO2peak predicted from SST was compared to the VO2peak directly measured with CPET. The reliability of SST was assessed by comparing repeated measures. Bland-Altman analysis was used to derive limits of agreement in validity and reliability analysis.ResultsSixty-six men provided data for both SST and CPET. These data were used for validity analysis. 56 men provided SST data on both visits. These data were used for reliability analysis. SST provided valid prediction of the cardiopulmonary fitness in men > 60 years old. The average difference between CPET and SST was 0.64 ml/kg/min with non-significant positive bias towards CPET (P = 0.217). Bland-Altman 95% limits of agreement of SST with CPET were ± 7.62 ml/kg/min. SST was reliable across the whole age range. Predicted VO2peak was on average 0.53 ml/kg/min higher at Visit 2 than at Visit 1 (P = 0.181). Bland-Altman 95% limits of agreement between repeated SST measures were ± 5.84 ml/kg/min.ConclusionsSST provides a valid and reliable alternative to CPET for the assessment of cardiopulmonary fitness in older men with prostate cancer. Caution is advised when assessing men 60 years old or younger because the VO2peak predicted with SST was significantly lower than that measured with CPET.

show abstract

“…There are androgen receptors in the brain and it is not surprising that withdrawal of testosterone has been linked to changes in verbal memory, visuospatial ability, and executive functions. A recent systematic review of the literature on cognitive effects in ADT found substantial variation in the rates reported and the magnitudes of effects because of heterogeneity in the definitions and measurement tools used [10]. The length of follow-up for all studies was limited and varied, with no study having longer than 12 mo of follow-up.…”

mentioning

confidence: 99%

Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition

Izard

2020

European Urology Focus

View full text Add to dashboard Cite

Cognitive impairment among prostate cancer patients: An overview of reviews

Cited by 44 publications

References 56 publications

[Retracted] A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment

[Retracted] A Prediction Model for Cognitive Impairment Risk in Colorectal Cancer after Chemotherapy Treatment

The Siconolfi step test: a valid and reliable assessment of cardiopulmonary fitness in older men with prostate cancer

Androgen Deprivation Therapy and Mental Health: Impact on Depression and Cognition

Contact Info

Product

Resources

About